- Report
- February 2025
- 150 Pages
Global
From €4604EUR$4,850USD£3,884GBP
- Report
- February 2025
- 143 Pages
Global
From €2847EUR$2,999USD£2,402GBP
- Report
- May 2024
- 130 Pages
Global
From €3750EUR$3,950USD£3,163GBP
- Report
- July 2024
- 150 Pages
Global
From €3560EUR$3,750USD£3,003GBP
- Report
- July 2024
- 100 Pages
Global
From €3560EUR$3,750USD£3,003GBP
- Report
- February 2025
- 182 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- January 2025
- 180 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- January 2025
- 182 Pages
Global
From €4742EUR$4,995USD£4,000GBP
- Report
- August 2024
- 180 Pages
Asia Pacific
From €3673EUR$3,869USD£3,098GBP
- Report
- July 2020
- 269 Pages
Global
From €3320EUR$3,497USD£2,800GBP
- Report
- October 2023
- 192 Pages
Global
From €4847EUR$5,284USD£3,950GBP
- Report
- December 2022
- 78 Pages
Global
From €5221EUR$5,500USD£4,404GBP
- Report
- January 2024
- 213 Pages
Global
From €4414EUR$4,650USD£3,724GBP
- Report
- September 2022
- 110 Pages
Global
From €5221EUR$5,500USD£4,404GBP
- Report
- May 2022
- 109 Pages
Global
From €5221EUR$5,500USD£4,404GBP
- Report
- February 2024
- 202 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- October 2022
- 194 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- November 2020
- 217 Pages
Global
From €3797EUR$4,000USD£3,203GBP
- Report
- April 2020
- 182 Pages
Global
From €3797EUR$4,000USD£3,203GBP
- Report
- September 2023
- 165 Pages
Global
From €2231EUR$2,350USD£1,882GBP

The Flu Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Flu Vaccines are specifically designed to protect against influenza, a highly contagious virus that can cause severe illness and even death. Flu Vaccines are typically administered annually, and are recommended for people of all ages, including pregnant women and those with chronic health conditions.
Flu Vaccines are typically developed by pharmaceutical companies, and are then approved and distributed by government health agencies. In addition to traditional flu vaccines, there are also recombinant vaccines, which are produced using genetic engineering techniques.
Companies in the Flu Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Novartis. Show Less Read more